Angelique Sijben

686 total citations
10 papers, 549 citations indexed

About

Angelique Sijben is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Angelique Sijben has authored 10 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Angelique Sijben's work include Glioma Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer Genomics and Diagnostics (3 papers). Angelique Sijben is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer Genomics and Diagnostics (3 papers). Angelique Sijben collaborates with scholars based in Netherlands, United States and Canada. Angelique Sijben's co-authors include Pieter Wesseling, Sandra Boots‐Sprenger, Judith W. M. Jeuken, Ian F. Parney, Peter Forsyth, Glòria Roldán, Elizabeth Yan, S.J.B. Cornelissen, Abdellatif Errami and Jos Rijntjes and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Epilepsia.

In The Last Decade

Angelique Sijben

9 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelique Sijben Netherlands 7 394 198 167 165 138 10 549
Mitsuaki Shirahata Japan 11 402 1.0× 188 0.9× 126 0.8× 161 1.0× 81 0.6× 37 573
Kristin Alfaro-Munoz United States 11 410 1.0× 129 0.7× 129 0.8× 137 0.8× 148 1.1× 28 546
Kay Ka‐Wai Li Hong Kong 13 352 0.9× 316 1.6× 129 0.8× 292 1.8× 95 0.7× 27 633
Kirsten Grunnet Denmark 14 494 1.3× 151 0.8× 179 1.1× 166 1.0× 154 1.1× 25 588
Thomas Urup Denmark 14 366 0.9× 192 1.0× 120 0.7× 171 1.0× 155 1.1× 30 585
Romain Appay France 14 467 1.2× 193 1.0× 177 1.1× 135 0.8× 109 0.8× 51 702
Nazia F. Jafri United States 8 222 0.6× 162 0.8× 106 0.6× 97 0.6× 113 0.8× 13 462
Jethro Hu United States 13 295 0.7× 139 0.7× 85 0.5× 112 0.7× 52 0.4× 34 471
Peggy N. Atmodimedjo Netherlands 15 573 1.5× 205 1.0× 254 1.5× 333 2.0× 224 1.6× 29 876
Ralf Ketter Germany 12 286 0.7× 97 0.5× 130 0.8× 87 0.5× 105 0.8× 25 515

Countries citing papers authored by Angelique Sijben

Since Specialization
Citations

This map shows the geographic impact of Angelique Sijben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelique Sijben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelique Sijben more than expected).

Fields of papers citing papers by Angelique Sijben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelique Sijben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelique Sijben. The network helps show where Angelique Sijben may publish in the future.

Co-authorship network of co-authors of Angelique Sijben

This figure shows the co-authorship network connecting the top 25 collaborators of Angelique Sijben. A scholar is included among the top collaborators of Angelique Sijben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelique Sijben. Angelique Sijben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Kuilenburg, André B. P., Angelique Sijben, Thijs H. Oude Munnink, et al.. (2024). Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants. JCO Precision Oncology. 8(8). e2300599–e2300599. 1 indexed citations
3.
Boots‐Sprenger, Sandra, Angelique Sijben, Jos Rijntjes, et al.. (2013). Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. Modern Pathology. 26(7). 922–929. 83 indexed citations
4.
Jeuken, Judith W. M., Angelique Sijben, Fonnet E. Bleeker, et al.. (2010). The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story”. Brain Pathology. 21(3). 308–320. 17 indexed citations
5.
Sijben, Angelique, Pasiri Sithinamsuwan, Radwa A.B. Badawy, et al.. (2009). Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+?. Epilepsia. 50(4). 953–956. 15 indexed citations
6.
Jeuken, Judith W. M., Angelique Sijben, Cristina Alenda, et al.. (2009). Robust Detection of EGFR Copy Number Changes and EGFR Variant III: Technical Aspects and Relevance for Glioma Diagnostics. Brain Pathology. 19(4). 661–671. 65 indexed citations
7.
Roldán, Glòria, Angelique Sijben, John B. McIntyre, et al.. (2008). Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. Journal of Clinical Oncology. 26(15_suppl). 2054–2054. 6 indexed citations
8.
Sijben, Angelique, John B. McIntyre, Glòria Roldán, et al.. (2008). Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. Journal of Neuro-Oncology. 89(1). 97–103. 113 indexed citations
9.
Brown, Robert A., Magdalena C. Ƶlatescu, Angelique Sijben, et al.. (2008). The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma. Clinical Cancer Research. 14(8). 2357–2362. 99 indexed citations
10.
Jeuken, Judith W. M., S.J.B. Cornelissen, Abdellatif Errami, et al.. (2007). MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Laboratory Investigation. 87(10). 1055–1065. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuaki Shirahata Breakdown of academic impact, for papers by Kristin Alfaro-Munoz Breakdown of academic impact, for papers by Kay Ka‐Wai Li Breakdown of academic impact, for papers by Kirsten Grunnet Breakdown of academic impact, for papers by Thomas Urup Breakdown of academic impact, for papers by Romain Appay Breakdown of academic impact, for papers by Nazia F. Jafri Breakdown of academic impact, for papers by Jethro Hu Breakdown of academic impact, for papers by Peggy N. Atmodimedjo Breakdown of academic impact, for papers by Ralf Ketter
Rankless by CCL
2026